284 related articles for article (PubMed ID: 21868065)
21. A meta-analysis of pain response in the treatment of fibromyalgia.
Roskell NS; Beard SM; Zhao Y; Le TK
Pain Pract; 2011; 11(6):516-27. PubMed ID: 21199320
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis.
Alberti FF; Becker MW; Blatt CR; Ziegelmann PK; da Silva Dal Pizzol T; Pilger D
Clin Rheumatol; 2022 Jul; 41(7):1965-1978. PubMed ID: 35347488
[TBL] [Abstract][Full Text] [Related]
23. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
25. Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
Bidari A; Moazen-Zadeh E; Ghavidel-Parsa B; Rahmani S; Hosseini S; Hassankhani A
Daru; 2019 Jun; 27(1):149-158. PubMed ID: 30877484
[TBL] [Abstract][Full Text] [Related]
26. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis.
Häuser W; Petzke F; Üçeyler N; Sommer C
Rheumatology (Oxford); 2011 Mar; 50(3):532-43. PubMed ID: 21078630
[TBL] [Abstract][Full Text] [Related]
28. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis.
Tzellos TG; Toulis KA; Goulis DG; Papazisis G; Zampeli VA; Vakfari A; Kouvelas D
J Clin Pharm Ther; 2010 Dec; 35(6):639-56. PubMed ID: 21054455
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological management of fibromyalgia: a Bayesian network meta-analysis.
Migliorini F; Maffulli N; Eschweiler J; Knobe M; Tingart M; Colarossi G
Expert Rev Clin Pharmacol; 2022 Feb; 15(2):205-214. PubMed ID: 35184627
[TBL] [Abstract][Full Text] [Related]
30. Pregabalin for the treatment of fibromyalgia.
Smith MT; Moore BJ
Expert Opin Pharmacother; 2012 Jul; 13(10):1527-33. PubMed ID: 22725707
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia.
VanderWeide LA; Smith SM; Trinkley KE
J Clin Pharm Ther; 2015 Feb; 40(1):1-6. PubMed ID: 25294655
[TBL] [Abstract][Full Text] [Related]
32. An evidence-based review of pregabalin for the treatment of fibromyalgia.
Arnold LM; Choy E; Clauw DJ; Oka H; Whalen E; Semel D; Pauer L; Knapp L
Curr Med Res Opin; 2018 Aug; 34(8):1397-1409. PubMed ID: 29519159
[TBL] [Abstract][Full Text] [Related]
33. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
34. Current progress in the pharmacological therapy of fibromyalgia.
Rao SG
Expert Opin Investig Drugs; 2009 Oct; 18(10):1479-93. PubMed ID: 19732029
[TBL] [Abstract][Full Text] [Related]
35. Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
Marlow NM; Simpson KN; Vaughn IA; Jo A; Zoller JS; Short EB
Pain Pract; 2018 Feb; 18(2):154-169. PubMed ID: 28419725
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study.
Arnold LM; Schikler KN; Bateman L; Khan T; Pauer L; Bhadra-Brown P; Clair A; Chew ML; Scavone J;
Pediatr Rheumatol Online J; 2016 Jul; 14(1):46. PubMed ID: 27475753
[TBL] [Abstract][Full Text] [Related]
37. Treatment of fibromyalgia with antidepressants: a meta-analysis.
O'Malley PG; Balden E; Tomkins G; Santoro J; Kroenke K; Jackson JL
J Gen Intern Med; 2000 Sep; 15(9):659-66. PubMed ID: 11029681
[TBL] [Abstract][Full Text] [Related]
38. An update on pharmacotherapy for the treatment of fibromyalgia.
Calandre EP; Rico-Villademoros F; Slim M
Expert Opin Pharmacother; 2015 Jun; 16(9):1347-68. PubMed ID: 26001183
[TBL] [Abstract][Full Text] [Related]
39. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
[TBL] [Abstract][Full Text] [Related]
40. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports.
Straube S; Derry S; Moore RA; McQuay HJ
Rheumatology (Oxford); 2010 Apr; 49(4):706-15. PubMed ID: 20056767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
